ABOUT US

AMYLGEN’S APPROACH ?

French leading Preclinical CRO offering in vivo efficacy studies to better predict and anticipate clinical results

WHY AMYLGEN’S CRO ?

We may help you bringing a first and highly valuable proof of efficacy in vivo of your compound

LAST NEWS

  • Amylgen-Publication
  • Vitafoods-Amylgen
  • AMYLGEN-AmylCilcare-imgUne_2017-06
  • AMYLGEN-BioMelb-imgUne_2017-06
  • AMYLGEN-DefiVV-imgUne_2017-06

TWITTER FEED

UPCOMING EVENTS

  • Biofit380
  • CTAD2019-380
  • AMYLGEN_bio-europe_imgUne_2019-11
  • SFN
  • AMYLGEN_MeetInItaly_imgUne_2019-12